International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Bone Marker Standards (WG-BMS) has evaluated the clinical potential of bone turnover markers (BTMs) in the prediction of fracture risk and for monito...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Vasikaran, S, Cooper, C, Eastell, R, Griesmacher, A, Morris, H, Trenti, T, Kanis, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
door: Vasikaran, S, et al.
Gepubliceerd in: (2011)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
door: Vasikaran, S, et al.
Gepubliceerd in: (2011)

Recommendations for bone marker standards in osteoporosis: what, why and where to now?
door: Vasikaran, S, et al.
Gepubliceerd in: (2011)

Standardising biochemical assessment of bone turnover in osteoporosis.
door: Vasikaran, S, et al.
Gepubliceerd in: (2011)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
door: Delmas, P, et al.
Gepubliceerd in: (2005)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
door: Ström, O, et al.
Gepubliceerd in: (2011)

The International Osteoporosis Foundation: history, objectives and achievements.
door: Cooper, C, et al.
Gepubliceerd in: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
door: Cooper, C, et al.
Gepubliceerd in: (2009)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
door: Kanis, J, et al.
Gepubliceerd in: (1997)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
door: Cooper, C, et al.
Gepubliceerd in: (2012)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
door: Rizzoli, R, et al.
Gepubliceerd in: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
door: Rizzoli, R, et al.
Gepubliceerd in: (2011)

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
door: Diez-Perez, A, et al.
Gepubliceerd in: (2017)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
door: Kanis, J, et al.
Gepubliceerd in: (2008)

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.
door: Lips, P, et al.
Gepubliceerd in: (1997)

DIAGNOSIS OF OSTEOPOROSIS
door: JOHN A Kanis
Gepubliceerd in: (2016-12-01)

Treatment failure in osteoporosis.
door: Diez-Perez, A, et al.
Gepubliceerd in: (2012)

The Asia-Pacific Regional Audit-Epidemiology, costs, and burden of osteoporosis in India 2013: A report of International Osteoporosis Foundation
door: Ambrish Mithal, et al.
Gepubliceerd in: (2014-01-01)

National Osteoporosis Foundation of South Africa osteoporosis guideline
door: J. van Schoor
Gepubliceerd in: (2011-10-01)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
door: Harvey, N, et al.
Gepubliceerd in: (2016)

Comparison of the European and USA practice guidelines for Osteoporosis.
door: Kanis, J, et al.
Gepubliceerd in: (2000)

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
door: T. Songpatanasilp, et al.
Gepubliceerd in: (2016-12-01)

Analysis of Molecular Genetic Markers of Osteoporosis in Residents of the Russian Federation
door: R. V. Polibin, et al.
Gepubliceerd in: (2023-07-01)

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
door: Lips, P, et al.
Gepubliceerd in: (1999)

Foundations of chemistry in the laboratory /
door: 370910 Hein, Morris, et al.
Gepubliceerd in: (1986)

Modelling cost-effectiveness in osteoporosis
door: Kanis, J, et al.
Gepubliceerd in: (2008)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
door: Hans, D, et al.
Gepubliceerd in: (2011)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice
door: Hans, D, et al.
Gepubliceerd in: (2011)

Programming of osteoporosis and impact on osteoporosis risk.
door: Dennison, E, et al.
Gepubliceerd in: (2013)

Modern Laboratory Diagnosis of Osteoporosis
door: Zh.A. Klimova, et al.
Gepubliceerd in: (2014-10-01)

Osteoporosis.
door: Sambrook, P, et al.
Gepubliceerd in: (2006)

A meta-analysis of reference markers of bone turnover for prediction of fracture
door: Johansson, H, et al.
Gepubliceerd in: (2014)

The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia
door: Swan Sim Yeap
Gepubliceerd in: (2017-12-01)

Antidepressant medications and osteoporosis
door: Rizzoli, R, et al.
Gepubliceerd in: (2012)

Osteoporosis epidemiology in UK Biobank: a unique opportunity for international researchers.
door: Harvey, N, et al.
Gepubliceerd in: (2013)

The cost-effectiveness of alendronate in the management of osteoporosis.
door: Kanis, J, et al.
Gepubliceerd in: (2008)

A reappraisal of generic bisphosphonates in osteoporosis.
door: Kanis, J, et al.
Gepubliceerd in: (2012)

Osteoporosis in the Russian Federation: Problems and Perspectives
door: Olga Mikhailovna Lesnyak, et al.
Gepubliceerd in: (2010-10-01)

Biochemical Markers of Bone Resorption Compared with Estimates of Bone Resorption from Radiotracer Kinetic Studies in Osteoporosis
door: Eastell, R, et al.
Gepubliceerd in: (1997)

Treatment of osteoporosis in men.
door: Kaufman, J, et al.
Gepubliceerd in: (2013)